# Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients

> **NCT07164326** · NA · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Pressor Response

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT07164326
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2026-11-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07164326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07164326, "Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07164326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*